E-LIB Suche - Ergebnisse für: Barbier, Liese

1

Personalized and longitudinal electronic informed consent i..:

De Sutter, Evelien ; Barbier, Liese ; Borry, Pascal...
DIGITAL HEALTH. 10 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

2

Heart failure patients' perspectives on treatment outcomes ..:

Vanneste, Alice ; Barbier, Liese ; Missotten, Ramses...
ESC Heart Failure. , 2024

Link: https://doi.org/10.1002/..

3

Biosimilars: Principles, Regulatory Framework, and Societal..:

, In: Pharmaceutical Biotechnology,

Vulto, Arnold G. ; Barbier, Liese - p. 267-281 , 2024

Link: https://doi.org/10.1007/..

4

Mapping Health Technology Assessment Agency Approaches for ..:

Barcina Lacosta, Teresa ; Inotai, András ; Pereira, Catarina Lopes..
Value in Health. 27 (2024) 5 - p. 543-551 , 2024

Link: https://doi.org/10.1016/..

5

Opportunities and Challenges in Cross-Country Collaboration..:

Claessens, Zilke ; Lammens, Michiel ; Barbier, Liese.
Journal of Market Access & Health Policy. 12 (2024) 3 - p. 144-157 , 2024

Link: https://doi.org/10.3390/..

6

Informing a European guidance framework on electronic infor..:

De Sutter, Evelien ; Borry, Pascal ; Huys, Isabelle.
BMC Health Services Research. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Recommendations on TNFα inhibitor biosimilar use in clinica..:

Meijboom, Rosanne W ; Barbier, Liese ; Druedahl, Louise C...
Expert Opinion on Biological Therapy. 23 (2023) 8 - p. 801-817 , 2023

Link: https://doi.org/10.1080/..

8

Uncertainty management in regulatory and health technology ..:

Hogervorst, Milou Amber ; Vreman, Rick ; Heikkinen, Inkatuuli...
International Journal of Technology Assessment in Health Care. 39 (2023) 1 - p. , 2023

Link: https://doi.org/10.1017/..

9

How can patient preferences be used and communicated in the..:

Janssens, Rosanne ; Barbier, Liese ; Muller, Mireille...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

10

Correction to: Interchangeability of Biosimilars: Overcomin..:

Barbier, Liese ; Vulto, Arnold G.
Drugs. 82 (2022) 6 - p. 717-717 , 2022

Link: https://doi.org/10.1007/..

11

Biosimilar Use and Switching in Belgium: Avenues for Integr..:

Barbier, Liese ; Simoens, Steven ; Declerck, Paul..
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

12

How to select a best-value biological medicine? A practical..:

Barbier, Liese ; Vandenplas, Yannick ; Boone, Niels...
American Journal of Health-System Pharmacy. 79 (2022) 22 - p. 2001-2011 , 2022

Link: https://doi.org/10.1093/..

13

Perceptions About Biosimilar Medicines Among Belgian Patien..:

Vandenplas, Yannick ; Barbier, Liese ; Simoens, Steven...
Frontiers in Pharmacology. 12 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

14

How to balance valuable innovation with affordable access t..:

Simoens, Steven ; Abdallah, Khadidja ; Barbier, Liese...
Frontiers in Pharmacology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

15

Regulatory Information and Guidance on Biosimilars and Thei..:

Barbier, Liese ; Mbuaki, Allary ; Simoens, Steven...
Frontiers in Medicine. 9 (2022) - p. , 2022

Link: https://doi.org/10.3389/..